NASDAQ · Biotechnology

GeoVax Labs Inc (GOVX)

$0.17 -9.31%
Add alert See all oversold stocks →
17 Oversold Daily RSI (14) · 30 Oct 2026

Moving averages

SMA 200$1.55-89.12%

Company profile

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified vaccinia ankara virus-like particle vaccine platform. The company is headquartered in Smyrna, Georgia.

SectorHealthcare
IndustryBiotechnology
Market cap$2.85M
P/E ratioNone
EPS$-8.70
Beta3.686
Dividend yield0.00%
52-week high$15.75
52-week low$0.26

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 41 VRTX Vertex Pharmaceuticals Inc RSI 68 CRSP CRISPR Therapeutics AG RSI 48 IOVA Iovance Biotherapeutics Inc RSI 30 VRAX Virax Biolabs Group Ltd - Class A RSI 27 ARTL Artelo Biosciences Inc RSI 29 ZVSA ZyVersa Therapeutics Inc RSI 15 SKYE Skye Bioscience Inc RSI 31 IMNN Imunon Inc RSI 36 ACXP Acurx Pharmaceuticals Inc RSI 27
30 days of PRO Unlimited free, no card

RSI alerts for GOVX

An email when GOVX closes below RSI 30 or above 70. Nothing else.

Add alert

Data last updated 13 October 2026 at 9:42 PM EDT